Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients
CD163+ M2 macrophages have been suggested to counteract tumor immunity by increasing immunosuppressive mechanisms including PD-L1 and IL-10 expression. Soluble levels of PD-L1, IL-10, and CD163 have been reported as potential biomarkers in various cancers, although the prognostic value in renal cell...
| 出版年: | Diagnostics |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2022-01-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2075-4418/12/2/336 |
